• Latest Posts

Seven pharma companies form alliance to prepare for future pandemics 

AbbVie takes step forward in Europe with migraine drug

Five recent advancements in Parkinson’s disease research

UK approval for AbbVie Crohn’s disease drug

AbbVie bets on Anima mRNA modulators to tackle cancer


Deep Science Ventures and AbbVie to create companies to target inflammatory diseases

Gate Neurosciences emerges from stealth to tackle CNS diseases

Formulations of Arecor Therapeutics’ drug to treat inflammatory diseases granted patents

Sosei Heptares and AbbVie enter second collaboration targeting neurological diseases

Positive results for drug combination used to treat rare blood cancer

French Juvisé buys gastro product in €400M finance deal